At a glance
- Originator AstraZeneca
- Class Antidementias; Antiulcers; Antivirals; Calcium regulators; Macrolides; Neuroprotectants; Osteoporosis therapies
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Gastrointestinal disorders; Influenza virus infections; Postmenopausal osteoporosis